Deep

BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression

Retrieved on: 
Tuesday, March 28, 2023
Depression, Brainsway, Transcranial magnetic stimulation, Psychiatry Research, Data analysis, Patient, Deep, TASE, Health, Pharmaceutical industry

BURLINGTON, Mass. and JERUSALEM, March 28, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of an expansive post-marketing data analysis demonstrating high response and remission rates for depression and anxious depression patients undergoing Deep Transcranial Magnetic Stimulation (Deep TMS™) treatment. The data, published in Psychiatry Research, showed the substantial benefits of Deep TMS treatment for depression, with patients who had received 30 or more treatments achieving an 82% response rate and a 65% remission rate.

Key Points: 
  • The data, published in Psychiatry Research, showed the substantial benefits of Deep TMS treatment for depression, with patients who had received 30 or more treatments achieving an 82% response rate and a 65% remission rate.
  • “BrainsWay is pleased to share this real-world evidence on Deep TMS, as it further validates the immense potential of this treatment in addressing the global mental health crisis,” said Hadar Levy, Chief Executive Officer of BrainsWay.
  • Data from questionnaires which are not specific to depression, and thus less relevant for assessing depression changes, were intentionally excluded.
  • “BrainsWay would like to thank all of the valued customers, partners, and patients involved in collecting, compiling, and analyzing this data.

Aspira Women’s Health Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Wednesday, March 22, 2023
Experiential learning, Employment, Optimism, Travel, Frontiers in Medicine, Executive, Information technology, Marketing, Risk assessment, Woman, Research, Gynaecology, American Medical Association, Medicare, Investment, Risk, Deep, Growth, PLA, FDA, Ovarian cancer, Video game, Pharmaceutical industry, Cryptocurrency, Medicaid, Aspira, Medicine

AUSTIN, Texas, March 22, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today reported its financial results for the fourth quarter and year ended December 31, 2022.

Key Points: 
  • Our purpose-driven focus on execution and prudent use of resources will be the key to positioning Aspira as a leader in women’s gynecologic health diagnostics.
  • Continued focus on disciplined spending, reducing cash utilization to $7.1 million in the fourth quarter of 2022, compared to $10.2 million in the first quarter of 2022.
  • Aspira utilized $7.1 million in the fourth quarter of 2022 compared to $7.6 million in the fourth quarter of 2021.
  • Aspira will host a conference call with investors today, March 22, 2023 at 4:30 pm Eastern Time to discuss financial results and provide a corporate update.

Global Deep Learning in Drug Discovery and Diagnostics Market to 2035: Ongoing Pace of Innovation Drives Growth

Retrieved on: 
Thursday, March 16, 2023
Research, Machine learning, Drug discovery, Brain, Deep learning, Software, Computer, Algorithm, Health, Market, Drug design, Diagnosis, Geography, Information services, Neuron, Intelligence, Artificial intelligence, Roger Hawkins (drummer), Medical device, Information technology, Medical imaging, Pharmaceutical industry, Deep

What is the Current Market Landscape of the Deep Learning Market Focused on Drug Discovery and Diagnostics?

Key Points: 
  • What is the Current Market Landscape of the Deep Learning Market Focused on Drug Discovery and Diagnostics?
  • Question 6: Which therapeutic area accounts for the largest share in the deep learning for drug discovery market?
  • Answer: Presently, oncological disorders capture the largest share (close to 40%) of the deep learning in drug discovery market.
  • Question 7: Which region is expected to witness the highest growth rate in the deep learning market for diagnostics?

Global Deep Learning Market in Drug Discovery and Diagnostics Market Report 2023: Players Include Aegicare, Aiforia Technologies, Ardigen, Berg and Google - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 16, 2023
Health, Pharmaceutical, Drug discovery, Deep learning, Software, Algorithm, Market, Diagnosis, Geography, Information services, Roger Hawkins (drummer), Medical device, Pharmaceutical industry, Medical imaging, Deep

What is the Current Market Landscape of the Deep Learning Market Focused on Drug Discovery and Diagnostics?

Key Points: 
  • What is the Current Market Landscape of the Deep Learning Market Focused on Drug Discovery and Diagnostics?
  • What is the Market Size of Deep Learning in Drug Discovery?
  • The global deep learning market focusing on drug discovery is anticipated to grow at a CAGR of over 20% between 2023 and 2035.
  • By 2035, the deep learning in drug discovery market for oncological disorders is expected to capture the majority share.

BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights

Retrieved on: 
Wednesday, March 15, 2023
OCD, Depression, TASE, Tic disorder, Comparison, Deep, Brainsway, TMS, Journal, Railroad Retirement Board, Transcranial magnetic stimulation, Total, DSM-IV codes, Cryptocurrency, Management, Dietary supplement, Video game

and JERUSALEM, March 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2022 financial results and provided an operational update.

Key Points: 
  • and JERUSALEM, March 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2022 financial results and provided an operational update.
  • Gross margin for the fourth quarter of 2022 was 71%, compared to 77% for the fourth quarter 2021.
  • Operating expenses for the fourth quarter of 2022 totaled $8.6 million, compared to $8.0 million for the fourth quarter of 2021.
  • Operating loss for the fourth quarter of 2022 was $4.3 million, compared to a loss of $1.5 million for the same period in 2021.

Capella Provides Update on Scout Drilling at the Kjøli Copper Project, Norway

Retrieved on: 
Wednesday, February 22, 2023
FRA, Anomaly, Lac Minerals Ltd v International Corona Resources Ltd, VMS, EM, Deep, Mining, Lithium, Printed circuit board, Capella

Six holes for 1,080m of drilling have been completed to date on targets along the Kjøli Mine trend (Kjøli Mine and Guldalsgruva sectors) and at Kjøli Deeps (a coincident electromagnetic and gravity anomaly underlying the former Kjøli copper mine) (Figure 1).

Key Points: 
  • Six holes for 1,080m of drilling have been completed to date on targets along the Kjøli Mine trend (Kjøli Mine and Guldalsgruva sectors) and at Kjøli Deeps (a coincident electromagnetic and gravity anomaly underlying the former Kjøli copper mine) (Figure 1).
  • Remobilized, semi-massive copper-rich (chalcopyrite-pyrrhotite) mineralization has been locally intersected in drilling along the Kjøli Mine trend, especially around Guldalsgruva.
  • A scout diamond drill program of approximately 1,250m was initiated at the Kjøli copper-zinc-cobalt project in late-January.
  • A total of six holes / 1,080m of drilling has been completed to date on targets along the Kjøli Mine trend (Kjøli Mine and Guldalsgruva sectors) and Kjøli Deeps (a coincident electromagnetic and gravity anomaly underlying the former Kjøli copper mine) (Table 1).

LLYC Announces Strong 2022 Earnings Preview, with 36% YOY Increase in Revenue

Retrieved on: 
Thursday, January 26, 2023
Media, Social Media, Professional Services, Search Engine Marketing, Other Communications, Digital Marketing, Public Relations, Investor Relations, Marketing, Advertising, Communications, Content Marketing, Consulting, Uncertainty, FIAP, Cannes Lions International Festival of Creativity, EBITDA, Apache, Face, Workforce, International, Growth, PRWeek, Deep, Eikon, Multimedia, MIT Center for Digital Business, Video game

International communications consulting firm LLYC closed 2022 with strong growth, as shown in its unaudited earnings preview.

Key Points: 
  • International communications consulting firm LLYC closed 2022 with strong growth, as shown in its unaudited earnings preview.
  • Meanwhile, LLYC’s U.S. operation confirmed its great potential for growth and profitability, contributing 7% of the company’s 2022 earnings.
  • (Graphic: Business Wire)
    “Despite the uncertainty, 2022 has been a good year for the firm,” shared Jose Antonio Llorente, Founding Partner and President of LLYC.
  • LLYC has nearly doubled in size since 2020, with total revenue up 99%, operating revenue up 81%, and EBITDA up 90%.

Joseph James - "Valentine" Single Release

Retrieved on: 
Monday, February 13, 2023
Deep Purple, Sirius XM, DM, Radio, IHeartRadio, Kiss FM, Cumulus cloud, Deep, Bono, Multimedia, Billboard, Social media, Name, Music, Online shopping, Audacy

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- "Valentine" is Joseph James' debut single released worldwide on January 2nd, 2023, and currently #22 on the Billboard AC chart.

Key Points: 
  • NEW YORK, Feb. 13, 2023 /PRNewswire/ -- "Valentine" is Joseph James' debut single released worldwide on January 2nd, 2023, and currently #22 on the Billboard AC chart.
  • This debut single will soon be followed by 10 more powerhouse tracks on Joseph's debut album, '5.5.'
  • Joseph is an award-winning mainstream singer-songwriter and producer from New York, and the founder of AP Music Group.
  • Joseph has performed, produced and toured with major acts all over the world.

Semiconductor Stepper Systems Market to Reach $45.0 Billion, Globally, by 2031 at 9.5% CAGR: Allied Market Research

Retrieved on: 
Thursday, February 2, 2023
Vaccine, Chart, COVID-19, Extreme, OEM, Business, Table, EUV, Advanced packaging (semiconductors), Growth, DUV, HVM, PDF, Communication, MEMS, Robotics, AI, Electric motor, Semiconductor, Deep

PORTLAND, Ore., Feb. 2, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Semiconductor Stepper Systems Market by Type (Extreme ultraviolet (EUV), Deep ultraviolet (DUV)), by Business (OEM, Aftermarket), by Application (Micro-Electro- Mechanical System (MEMS), LED Devices, Advanced Packaging): Global Opportunity Analysis and Industry Forecast, 2021-2031" According to the report, the global semiconductor stepper systems industry generated $18.2 billion in 2021, and is anticipated to generate $45.0 billion by 2031, witnessing a CAGR of 9.5% from 2022 to 2031.

Key Points: 
  • Rise in demand for semiconductor stepper systems from end use industries such as automotive, medical, robotics, communication, consumer electronics, and others drive the growth of the global semiconductor stepper systems market.
  • Furthermore, the gradual increasing adoption of AI-enabled chips connected devices across the globe is anticipated to positively affect the semiconductor stepper systems market growth.
  • Moreover, major businesses in the semiconductor stepper systems market offer a wide range of products, to meet customers' needs.
  • The outbreak of the Covid-19 pandemic had a negative impact on the global semiconductor stepper systems market, owing to temporary closure of the production of many components in the semiconductor stepper systems market during the lockdown.

Semiconductor Stepper Systems Market to Reach $45.0 Billion, Globally, by 2031 at 9.5% CAGR: Allied Market Research

Retrieved on: 
Thursday, February 2, 2023
Vaccine, Chart, COVID-19, Extreme, OEM, Business, Table, EUV, Advanced packaging (semiconductors), Growth, DUV, HVM, PDF, Communication, MEMS, Robotics, AI, Electric motor, Semiconductor, Deep

PORTLAND, Ore., Feb. 2, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Semiconductor Stepper Systems Market by Type (Extreme ultraviolet (EUV), Deep ultraviolet (DUV)), by Business (OEM, Aftermarket), by Application (Micro-Electro- Mechanical System (MEMS), LED Devices, Advanced Packaging): Global Opportunity Analysis and Industry Forecast, 2021-2031" According to the report, the global semiconductor stepper systems industry generated $18.2 billion in 2021, and is anticipated to generate $45.0 billion by 2031, witnessing a CAGR of 9.5% from 2022 to 2031.

Key Points: 
  • Rise in demand for semiconductor stepper systems from end use industries such as automotive, medical, robotics, communication, consumer electronics, and others drive the growth of the global semiconductor stepper systems market.
  • Furthermore, the gradual increasing adoption of AI-enabled chips connected devices across the globe is anticipated to positively affect the semiconductor stepper systems market growth.
  • Moreover, major businesses in the semiconductor stepper systems market offer a wide range of products, to meet customers' needs.
  • The outbreak of the Covid-19 pandemic had a negative impact on the global semiconductor stepper systems market, owing to temporary closure of the production of many components in the semiconductor stepper systems market during the lockdown.